{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:51Z","timestamp":1792532391620,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Medical Science and Technology Research Program of Henan Province, Joint Project","award":["LHGJ20220398"],"award-info":[{"award-number":["LHGJ20220398"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03448-7","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:51:13Z","timestamp":1792475473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MG53 suppresses the progression of bladder cancer through E3 ubiquitin ligase-mediated degradation of AMPK\u03b1"],"prefix":"10.1007","volume":"43","author":[{"given":"Xiangfei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"3448_CR1","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.3322\/caac.21820","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76:e70043. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"3448_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2010.01.009","volume":"193","author":"D Volanis","year":"2010","unstructured":"Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V. Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol Lett. 2010;193:131\u20137. https:\/\/doi.org\/10.1016\/j.toxlet.2010.01.009.","journal-title":"Toxicol Lett"},{"key":"3448_CR3","doi-asserted-by":"publisher","first-page":"1537808","DOI":"10.3389\/fimmu.2025.1537808","volume":"16","author":"P Huang","year":"2025","unstructured":"Huang P, Wang J, Yu Z, Lu J, Sun Z, Chen Z. Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion. Front Immunol. 2025;16:1537808. https:\/\/doi.org\/10.3389\/fimmu.2025.1537808.","journal-title":"Front Immunol"},{"key":"3448_CR4","doi-asserted-by":"publisher","first-page":"1377025","DOI":"10.3389\/fphys.2024.1377025","volume":"15","author":"YF Wang","year":"2024","unstructured":"Wang YF, An ZY, Li JW, Dong ZK, Jin WL. MG53\/TRIM72: multi-organ repair protein and beyond. Front Physiol. 2024;15:1377025. https:\/\/doi.org\/10.3389\/fphys.2024.1377025.","journal-title":"Front Physiol"},{"key":"3448_CR5","doi-asserted-by":"publisher","unstructured":"Li J, Shen J, Li T, Wang L. Recombinant human mitsugumin 53: a potential therapeutic agent for multiple diseases. Front Pharmacol. 2025;16. https:\/\/doi.org\/10.3389\/fphar.2025.1537808.","DOI":"10.3389\/fphar.2025.1537808"},{"key":"3448_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coph.2021.04.007","volume":"59","author":"BA Whitson","year":"2021","unstructured":"Whitson BA, Tan T, Gong N, Zhu H, Ma J. Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration. Curr Opin Pharmacol. 2021;59:26\u201332. https:\/\/doi.org\/10.1016\/j.coph.2021.04.007.","journal-title":"Curr Opin Pharmacol"},{"key":"3448_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2337\/dbi24-0019","volume":"74","author":"S Yuan","year":"2025","unstructured":"Yuan S, Yu Q, Luo M, Wu J, Wang L. Friend or foe: the paradoxical roles of MG53 in diabetes. Diabetes. 2025;74:145\u201352. https:\/\/doi.org\/10.2337\/dbi24-0019.","journal-title":"Diabetes"},{"key":"3448_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41389-022-00416-6","volume":"11","author":"X Ma","year":"2022","unstructured":"Ma X, Ma X, Zhu L, Zhao Y, Chen M, Li T, et al. The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling. Oncogenesis. 2022;11:40. https:\/\/doi.org\/10.1038\/s41389-022-00416-6.","journal-title":"Oncogenesis"},{"key":"3448_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41419-023-06219-6","volume":"14","author":"YB Wu","year":"2023","unstructured":"Wu YB, Li SY, Liu JY, Xue JJ, Xu JF, Chen T, et al. Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2\/beta-catenin pathway. Cell Death Dis. 2023;14:696. https:\/\/doi.org\/10.1038\/s41419-023-06219-6.","journal-title":"Cell Death Dis"},{"key":"3448_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-023-01506-6","volume":"8","author":"M Fang","year":"2023","unstructured":"Fang M, Wu HK, Pei Y, Zhang Y, Gao X, He Y, et al. E3 ligase MG53 suppresses tumor growth by degrading cyclin D1. Signal Transduct Target Ther. 2023;8:263. https:\/\/doi.org\/10.1038\/s41392-023-01506-6.","journal-title":"Signal Transduct Target Ther"},{"key":"3448_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661\u20135. https:\/\/doi.org\/10.1038\/nature11066.","journal-title":"Nature"},{"key":"3448_CR12","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.31557\/APJCP.2025.26.9.3157","volume":"26","author":"AS Alhallaq","year":"2025","unstructured":"Alhallaq AS, Sultan NS. Fueling prostate cancer: the central role of glutamine\/glutamate metabolic reprogramming. Asian Pac J Cancer Prev. 2025;26:3157\u201374. https:\/\/doi.org\/10.31557\/APJCP.2025.26.9.3157.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3448_CR13","doi-asserted-by":"publisher","first-page":"188785","DOI":"10.1016\/j.bbcan.2022.188785","volume":"1877","author":"V Penugurti","year":"2022","unstructured":"Penugurti V, Mishra YG, Manavathi B. AMPK: an odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene. Biochim Biophys Acta Rev Cancer. 2022;1877:188785. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188785.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3448_CR14","first-page":"3718","volume":"11","author":"J Al-Maghrabi","year":"2018","unstructured":"Al-Maghrabi J, Qureshi IA, Butt NS, Khabaz MN. Phosphorylated AMP-activated protein kinase expression is significantly associated with poor clinical outcomes in bladder carcinoma patients. Int J Clin Exp Pathol. 2018;11:3718\u201325.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"3448_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, et al. Interferon-dependent SLC14A1\u2009+\u2009cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550\u2013e15657. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.005.","journal-title":"Cancer Cell"},{"issue":"6","key":"3448_CR16","doi-asserted-by":"publisher","first-page":"152410","DOI":"10.1016\/j.seminoncol.2025.152410","volume":"52","author":"J Gupta","year":"2025","unstructured":"Gupta J, Al-Khateeb FN, Zwenal A, et al. Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance. Semin Oncol. 2025;52(6):152410. https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152410.","journal-title":"Semin Oncol"},{"key":"3448_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.molcel.2020.12.008","volume":"81","author":"P Jiang","year":"2021","unstructured":"Jiang P, Ren L, Zhi L, Yu Z, Lv F, Xu F, et al. Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53. Mol Cell. 2021;81:629\u201337. https:\/\/doi.org\/10.1016\/j.molcel.2020.12.008.","journal-title":"Mol Cell"},{"key":"3448_CR18","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.tranon.2024.102118","volume":"50","author":"XL Wang","year":"2024","unstructured":"Wang XL, He X, Gao T, Zhou X, Cruz-Monserrate Z, Tsung A, et al. MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer. Transl Oncol. 2024;50:102118. https:\/\/doi.org\/10.1016\/j.tranon.2024.102118.","journal-title":"Transl Oncol"},{"key":"3448_CR19","doi-asserted-by":"publisher","unstructured":"Li H, Lin PH, Gupta P, Li X, Zhao SL, Zhou X, et al. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer. Mol Cancer. 2021;20. https:\/\/doi.org\/10.1186\/s12943-021-01322-w.","DOI":"10.1186\/s12943-021-01322-w"},{"key":"3448_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/CAD.0000000000001291","volume":"33","author":"Z Wang","year":"2022","unstructured":"Wang Z, Li H, Wang H, Li X, Zhang Q, Wang H, et al. TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA. Anticancer Drugs. 2022;33:489\u2013501. https:\/\/doi.org\/10.1097\/CAD.0000000000001291.","journal-title":"Anticancer Drugs"},{"key":"3448_CR21","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/cancers17122070","volume":"17","author":"MI Ehrlich","year":"2025","unstructured":"Ehrlich MI, Fox RD, Runcie KD, Stein MN, Wei AZ. Novel strategies and therapeutic advances for bladder cancer. Cancers. 2025;17:2070. https:\/\/doi.org\/10.3390\/cancers17122070.","journal-title":"Cancers"},{"key":"3448_CR22","doi-asserted-by":"publisher","unstructured":"Wan X, Wang D, Zhang X, Xu M, Huang Y, Qin W, et al. Unleashing the power of urine-based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (review). Int J Oncol. 2025;66. https:\/\/doi.org\/10.3892\/ijo.2025.5731.","DOI":"10.3892\/ijo.2025.5731"},{"key":"3448_CR23","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1111\/cas.15062","volume":"112","author":"JE Burns","year":"2021","unstructured":"Burns JE, Hurst CD, Knowles MA, Phillips RM, Allison SJ. The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets. Cancer Sci. 2021;112:3822\u201334. https:\/\/doi.org\/10.1111\/cas.15062.","journal-title":"Cancer Sci"},{"key":"3448_CR24","doi-asserted-by":"publisher","unstructured":"Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Goncalves SM, Mendes-Alves C, et al. Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming beyond the Warburg effect. Cancers. 2024;16. https:\/\/doi.org\/10.3390\/cancers16010207.","DOI":"10.3390\/cancers16010207"},{"key":"3448_CR25","doi-asserted-by":"publisher","unstructured":"Desbats MA, Giacomini I, Prayer-Galetti T, Montopoli M. Metabolic plasticity in chemotherapy resistance. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.00281.","DOI":"10.3389\/fonc.2020.00281"},{"issue":"5","key":"3448_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981\u201390. https:\/\/doi.org\/10.1016\/j.cellsig.2012.01.008.","journal-title":"Cell Signal"},{"issue":"2","key":"3448_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative Stress in Cancer. Cancer Cell. 2020;38(2):167\u201397. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001.","journal-title":"Cancer Cell"},{"key":"3448_CR28","doi-asserted-by":"publisher","unstructured":"Lu H, Mei C, Yang L, Zheng J, Tong J, Duan F, et al. PPM-18, an analog of vitamin K, induces autophagy and apoptosis in bladder cancer cells through ROS and AMPK signaling pathways. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.639250.","DOI":"10.3389\/fphar.2021.639250"},{"key":"3448_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/ol.2019.11107","volume":"19","author":"D Gan","year":"2020","unstructured":"Gan D, He W, Yin H, Gou X. \u03b2-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway. Oncol Lett. 2020;19:291\u2013300. https:\/\/doi.org\/10.3892\/ol.2019.11107.","journal-title":"Oncol Lett"},{"key":"3448_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11834","volume":"494","author":"R Song","year":"2013","unstructured":"Song R, Peng W, Zhang Y, Lv F, Wu HK, Guo J, et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494:375\u20139. https:\/\/doi.org\/10.1038\/nature11834.","journal-title":"Nature"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03448-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:03:03Z","timestamp":1792530183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03448-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3448"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03448-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Declaration of Generative AI and AI-Assisted Technologies in the Manuscript Preparation Process. (I used the SCISPACE AI tool to format the layout of the paper).","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No.: 2022-KY-1274; approval date: 09-15-2022). Animal experiments were approved by the Institutional Animal Care and Use Committee of Zhengzhou University (Approval No.: 2022-KY-1274; approval date: 09-15-2022). Written informed consent was obtained from all human subjects involved in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"337"}}